Trial Profile
A randomized, open-label trial of telbivudine versus adefovir dipivoxil in adults With HBegAg [Hepatitis B e antigen]-positive, compensated chronic hepatitis B
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 May 2015
Price :
$35
*
At a glance
- Drugs Telbivudine (Primary) ; Adefovir dipivoxil
- Indications Hepatitis B
- Focus Adverse reactions; Therapeutic Use
- Sponsors Idenix Pharmaceuticals; Merck Sharp & Dohme
- 04 Dec 2007 Results have been published
- 24 May 2007 Interim results have been reported at DDW.
- 11 Dec 2006 Status change